Trajan builds microscopy portfolio

Trajan builds microscopy portfolio

March 07, 2016

With a strong background in specialty glass and coatings Trajan Scientific and Medical (Trajan) has introduced a new range of microscopy products.

Trajan's General Manager, Microscopy Products, Ms Angela Tomisich says that microscopy is a key technique where premium products can be brought to market to have a positive impact on patient outcomes, in line with the Trajan vision.

“By working closely with partners in pathology and healthcare, we want to continue to develop our range of products in ways that have a positive impact on the diagnostic process. In a world that is increasingly driven to drive down healthcare costs, we want to play a strong role in ensuring that patient outcomes are not compromised.” said Ms Tomisich.

Ms Tomisich is a Director on the Board of Trajan and brings a breadth of management and clinical research experience. She attained a Bachelor of Applied Science (Applied Chemistry) from RMIT, Melbourne, Australia, and Bachelor of Science (Biomedical Science) from Deakin University, Melbourne, Australia. In 2006, she was also placed on the Cornell University Dean’s List following a cell physiology and genomics program in Ithaca, USA.

Prior to Trajan, Ms Tomisich was involved the monitoring of clinical trials in Australia and New Zealand for protocols that were complex and required knowledge in advanced therapeutic areas, including oncology, cardiology, and neurology.

Ms Tomisich is also a member of the Digital Pathology Association, and has a keen interest in emerging methods and technologies to improve diagnostic practices.

For a preview of Trajan’s capabilities in microscopy products, please view the page below or contact the Trajan team directly to discuss your microscopy requirements.


Angela Tomisich, General Manager, Microscopy Products

More information
Microscopy Products




Also in News

Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare
Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare

April 16, 2021

Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Read More

Close-up of the LLE mixer tool on the Trajan Automation autosampler
Trajan’s “Lab-in-a-Syringe” product development program promises greater laboratory efficiencies

March 30, 2021

Trajan Scientific and Medical’s (Trajan) highly successful ASTech1 program has resulted in the commercial development of several new syringe technologies. The program was developed in collaboration with the University of Tasmania where the objective was to develop a range of “lab-in-a-syringe” applications, expanding on Trajan’s expertise in precision manufacturing of their industry leading analytical syringe portfolio.

Read More

Trajan takes 100% ownership of nutritional testing joint venture and commences expansion of Melbourne laboratories to provide broader analytical services
Trajan takes 100% ownership of nutritional testing joint venture and commences expansion of Melbourne laboratories to provide broader analytical services

March 02, 2021

In 2017 the joint venture between Trajan Scientific and Medical (Trajan) and leading experts in the field of nutrition, Professors Maria Makrides and Robert Gibson was established as Trajan Nutrition. The initial focus of Trajan Nutrition was to improve the health of mothers and their children through the provision of information to support the development of a personalized dietary pathway to better health. This still remains an important element of Trajan Nutrition’s work.

Read More